These CAR-iCD4+ T cells were co-cultured with the CD19+ acute lymphoblastic leukemia cell line NALM6 for a short-term (3-h) killing assay, as shown in Fig. 2E. CAR-transduced primary CD4+ and CD8+ T cells from different donors served as controls. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.